| scientific journal | Q5633421 |
| P495 | country of origin | Germany | Q183 |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| P407 | language of work or name | English | Q1860 |
| P1476 | title | European journal of clinical microbiology |
| Q54464350 | 3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests. |
| Q44642046 | A 168-kilodalton protein of Mycoplasma pneumoniae used as antigen in a dot enzyme-linked immunosorbent assay |
| Q43019171 | A blood-free medium for isolation of thermophilic Campylobacter species |
| Q70586184 | A case of cryptic Bacteroides fragilis septicemia |
| Q70470698 | A case of septicaemia caused by Bacillus cereus |
| Q70395116 | A collaborative evaluation of a rapid automated bacterial identification system: the Autobac IDX |
| Q70437156 | A comparison of microaerobic systems for the culture of Campylobacter jejuni and Campylobacter coli |
| Q70175030 | A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime |
| Q54471103 | A laboratory assessment of ciprofloxacin and comparable antimicrobial agents |
| Q70644496 | A latex agglutination technique for rapid, direct identification of pneumococci in blood cultures |
| Q43606455 | A luminescence Western blot with enhanced sensitivity for antibodies to human immunodeficiency virus |
| Q70087322 | A micromethod for endotoxin assay in human plasma using Limulus amoebocyte lysate and a chromogenic substrate |
| Q53849975 | A modified broth-disk antibiotic susceptibility test for Campylobacter jejuni. |
| Q70353612 | A modified method for differentiation ofHaemophilus influenzae fromHaemophilus parainfluenzae |
| Q70586186 | A modified method for testing the antimicrobial susceptibility of anaerobic gram-positive cocci |
| Q70395125 | A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam |
| Q68988467 | A new coagglutination test for detecting pneumococcal C-polysaccharide |
| Q64135522 | A new disk diffusion test for presumptive identification of group B streptococci |
| Q50208266 | A new micromethod for rapid detection of pathogenic bacteria in stool specimens |
| Q70634527 | A new selective medium for the culture of clostridia from human faeces |
| Q70290204 | A new selective medium for the isolation ofCampylobacter jejuni from human faeces |
| Q70388353 | A nosocomial epidemic of Serratia liquefaciens urinary tract infection after cystometry |
| Q68988485 | A note on name, viability and urease tests of Campylobacter pylori |
| Q68837502 | A penicillinase-producing Fusobacterium nucleatum strain isolated from blood culture |
| Q69589794 | A reassessment of sputum specimens for laboratory diagnosis of pneumococcal pneumonia |
| Q71066234 | A restaurant associated Campylobacter outbreak |
| Q69889061 | A simple method for the rapid identification of group A streptococci |
| Q70562392 | A timely remark on influenza |
| Q70250353 | ABAC Identibiogramme: Prototype of an automated system for identification of Enterobacteria |
| Q41530802 | AIDS - a new plague? |
| Q46914531 | AIDS: African connection |
| Q70671866 | Abdominal infections caused by Streptococcus pneumoniae |
| Q44734489 | Ability of a Staphylococcus aureus isolate from a chronic osteomyelitic lesion to survive in the absence of air. |
| Q68161258 | Ability of enzyme-linked immunosorbent assays to detect early immunoglobulin G antibodies to Toxoplasma gondii |
| Q68830883 | Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae |
| Q69589820 | Absence of mycobacterial antibody in patients with acquired immune deficiency syndrome |
| Q69897779 | Acellular pertussis vaccine in adults: adverse reactions and immune response |
| Q71296701 | Acquired immune deficiency syndrome (AIDS) in Europe |
| Q71296705 | Acquired immune deficiency syndrome in Belgium |
| Q71296730 | Acquired immune deficiency syndrome in France |
| Q71296725 | Acquired immune deficiency syndrome in Scandinavia |
| Q71296735 | Acquired immune deficiency syndrome in Switzerland |
| Q71296711 | Acquired immune deficiency syndrome in the Federal Republic of Germany |
| Q71296716 | Acquired immune deficiency syndrome in the Netherlands |
| Q71296720 | Acquired immune deficiency syndrome in the United Kingdom |
| Q43840097 | Acquisition of tetanus in the desert |
| Q72732924 | Acridine orange stain in the early detection of bacteria in blood cultures |
| Q53563575 | Acridine orange staining of smears for demonstration ofMycobacterium tuberculosis |
| Q93614502 | Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis |
| Q69056671 | Activity of LY146032 and vancomycin against coagulase-negative staphylococci |
| Q54741094 | Activity of carumonam and aztreonam against Klebsiella species. |
| Q70868720 | Activity of cephalosporins against methicillin-resistant coagulase-negative staphylococci |
| Q70395129 | Activity of imipenem against high inocula of Bacteroides species and Escherichia coli alone and in mixed culture |
| Q44923259 | Activity of new antimicrobial agents against Listeria monocytogenes |
| Q68737383 | Activity of newer antimicrobial agents against Aeromonas hydrophila |
| Q58001239 | Activity of sodium fusidate in vitro against anaerobic bacteria |
| Q54433710 | Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis. |
| Q69949845 | Adherence inhibition assay: a specific serological test for detection of antibodies to Mycoplasma pneumoniae |
| Q68894769 | Adherence of Trichomonas vaginalis to cell culture monolayers |
| Q54486348 | Adhesion of Proteus species to various cell types. |
| Q70223276 | Adult vertebral osteomyelitis caused byHaemophilus influenzae |
| Q68228499 | Adverse reactions and immunogenicity in adults to regular and increased dosage of diphtheria vaccine |
| Q54395942 | Aerococcus bacteremia associated with granulocytopenia. |
| Q69421598 | Aetiology and treatment of bacterial meningitis |
| Q44922047 | Amikacin-containing regimens for treatment of nocardiosis in immunocompromised patients |
| Q70515750 | An anti-human immunoglobulin M monoclonal antibody for detection of antibodies to Toxoplasma gondii |
| Q71462291 | An assay for measuring specific adhesion of an Escherichia coli strain to tissue culture cells |
| Q40254752 | An overview of the diagnosis and treatment of Gardnerella vaginalis and Bacteroides associated vaginitis |
| Q71842891 | Anaerobic bacteria in uterine infection following first trimester abortion |
| Q39741089 | Anaerobic meningitis in children |
| Q44460586 | Anaerobic radiometric detection of facultative Gram-positive cocci in blood |
| Q44817872 | Analysis of dimycocerosates of glycosylphenolphthiocerols in the identification of some clinically significant mycobacteria |
| Q53966061 | Analysis of gram-positive anaerobic cocci in oral, fecal and vaginal flora. |
| Q53900200 | Analysis of the interferon system in African patients with acquired immunodeficiency syndrome. |
| Q69954275 | Analysis of thirty-seven cases of pleural empyema |
| Q45208443 | Another look at trimethoprim-sulfamethoxazole: Its role in parenteral therapy |
| Q54470593 | Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis. |
| Q69056693 | Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid |
| Q71184240 | Antibiotic associated diarrhoea probably related to rifampicin |
| Q69421606 | Antibiotic interaction: interpretation of fractional inhibitory and fractional bactericidal concentration indices |
| Q69487965 | Antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography |
| Q54452281 | Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. |
| Q54424674 | Antibiotic resistance pattern of Flavobacterium meningosepticum. |
| Q70671869 | Antibiotic sensitivity of "Campylobacter pylori" |
| Q53840232 | Antibiotic susceptibility of Pasteurella multocida. |
| Q51213727 | Antibiotic-induced bacterial cell lysis: a therapeutic dilemma. |
| Q71066221 | Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes |
| Q40163147 | Antibiotics and Phagocytosis |
| Q70599027 | Antibody response following subcutaneous and intraperitoneal injection of Bacteroides fragilis in rabbits |
| Q71352300 | Antibody response of patas monkeys to experimental infection with Delta herpesvirus |
| Q58379882 | Antibody response to individual cytomegalovirus structural proteins in different groups of subjects |
| Q70274793 | Antibody response toShigella sonnei infection determined by an enzyme-linked immunosorbent assay |
| Q72683848 | Antibody-dependent cell-mediated cytotoxicity againstEscherichia coli O antigens |
| Q45830521 | Antigenic variations of respiratory syncytial virus in recurrent infections |
| Q40142222 | Antiherpes drugs: Promises and pitfalls |
| Q37902543 | Antimicrobial chemotherapy of chlamydial infection: where next? |
| Q44948025 | Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis |
| Q69996512 | Antimicrobial susceptibility of group B streptococci |
| Q45026049 | Antimicrobial therapy of streptococcal endocarditis |
| Q45829631 | Assay of hepatitis B virus genome titers in sera of infected subjects |
| Q70331816 | Assay of type-specific M antigens on whole group A streptococci |
| Q44593951 | Atrio-ventricular block associated with Shigella flexneri infection |
| Q69212216 | Automated bacteriuria screening using the Berthold LB 950 luminescence analyser |
| Q70250359 | Automation in the microbiology laboratory |
| Q37902557 | B cell response in Chlamydia trachomatis endometritis |
| Q70562404 | Bacteremic pneumococcal pneumonia: value of culture of nasopharyngeal specimens and examination of washed sputum specimens |
| Q68671173 | Bacteria in bile of patients with bile duct inflammation |
| Q68194937 | Bacteria isolated from skin and soft tissue lesions |
| Q64451411 | Bacterial adherence |
| Q54764639 | Bacterial interference by anaerobic species isolated from human feces. |
| Q54777448 | Bacterial resistance after in vitro exposure to amikacin and netilmicin. |
| Q68836886 | Bacterial vaginosis: microbiological and clinical findings |
| Q70395133 | Bactericidal activity of imipenem in broth, serum and in the presence of human polymorphonuclear leukocytes against staphylococcus aureus and Klebsiella pneumoniae |
| Q70963571 | Bactericidal activity of imipenem in serum |
| Q69981188 | Bacteriological study of renal calculi |
| Q70331838 | Beta-2 microglobulin: A sensitive non-specific marker of acquired immune deficiency syndrome |
| Q54762960 | Beta-lactamase alteration of beta-lactam inhibitory zones. |
| Q42216705 | Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892. |
| Q68809061 | Beta-lactamase production in the upper respiratory tract flora |
| Q37905141 | Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens |
| Q70997093 | Biliary tract infections caused by Haemophilus influenzae type b |
| Q67265859 | Binding of fibronectin to the surface of group A, C, and G streptococci isolated from human infections |
| Q72792129 | Bioassay procedures for norfloxacin |
| Q48429052 | Brain-abscess caused by Streptococcus bovis |
| Q58405863 | Brucellosis and parenteral drug abuse |
| Q40813586 | C-reactive protein and serum amyloid A levels in rickettsial spotted fever |
| Q69661769 | C-reactive protein in boutonneuse fever |
| Q46253808 | Campylobacter fetus subspecies jejuni in Senegal |
| Q68681324 | Candida albicans endocarditis possibly related to systemic candidiasis in a heroin addict |
| Q61839445 | Capnocytophaga bacteremia complicating premature delivery by cesarean section |
| Q68681336 | Capsular types and antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with systemic infections in West Germany |
| Q68228512 | Carbohydrate profiling of bacteria by gas chromatography-mass spectrometry: chemical derivatization and analytical pyrolysis |
| Q71824448 | Cardiobacterium hominis endocarditis |
| Q70283866 | Catheter sepsis due to coagulase-negative staphylococci in patients on total parenteral nutrition |
| Q70250347 | Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: A comparative double-blind study |
| Q93572671 | Ceftriaxone: a three centre comparative in vitro susceptibility study |
| Q69421589 | Cell-wall deficient bacteria in inflammatory bowel disease |
| Q39327283 | Changing fecal Escherichia coli flora during travel |
| Q70634536 | Characteristics of anaerobic comma-shaped bacteria recovered from the female genital tract |
| Q71099972 | Characterization of Staphylococcus saprophyticus strains isolated from the urethra and the vagina |
| Q54419186 | Characterization of an isogenic set of methicillin-resistant and susceptible mutants of Staphylococcus aureus. |
| Q70753592 | Characterization of endemic Providencia stuartii isolates from patients with urinary devices |
| Q41374911 | Chemotherapy of herpesvirus infections: present successes and future hopes |
| Q69661771 | Chlamydia trachomatis infections |
| Q37902526 | Chlamydial infections in children: a seroepidemiological study |
| Q37902597 | Chlamydial respiratory infection in childhood and spurious immunoglobulin M. |
| Q40809549 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study |
| Q42203654 | Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis |
| Q54430804 | Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria. |
| Q54782466 | Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria. |
| Q44957929 | Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis |
| Q54430800 | Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria. |
| Q69996515 | Ciprofloxacin: pharmacokinetics and clinical experience |
| Q39025048 | Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe |
| Q39818045 | Clinical applications of monoclonal antibodies |
| Q45072839 | Clinical consequences of development of resistance to third generation cephalosporins |
| Q72792135 | Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections |
| Q69996538 | Clinical evaluation of treatment with ciprofloxacin |
| Q50203682 | Clinical experience with ciprofloxacin in the USA. |
| Q39673645 | Clinical importance of inducible beta-lactamases in gram-negative bacteria |
| Q39502220 | Clinical isolates of Cryptococcus neoformans from Zaire |
| Q48464010 | Clinical significance of Streptococcus milleri |
| Q39673650 | Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods |
| Q70142188 | Clinical uses of nalidixic acid analogues: the fluoroquinolones |
| Q71296684 | Clostridium difficile colitis associated with the use of antineoplastic agents |
| Q61928105 | Clostridium difficile-Associated diarrhoea in uremic patients |
| Q70972017 | Clostridium difficile-associated diarrhoea during treatment with imipenem |
| Q70868722 | Clumping factor defective methicillin-resistant Staphylococcus aureus |
| Q54449797 | Colonization antigens and haemagglutination patterns of human Escherichia coli. |
| Q43576008 | Combination effect of azthreonam with four aminoglycosides on nosocomial gram-positive cocci and non-fermenting gram-negative bacteria. |
| Q68872325 | Commercial kit for preliminary identification of Staphylococcus saprophyticus in urine |
| Q69589825 | Commercial kit for preliminary identification of Staphylococcus saprophyticus in urine |
| Q69056685 | Commercial latex slide-agglutination test for rapid identification of Staphylococcus aureus |
| Q37901182 | Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis |
| Q69820153 | Comparative activity of LY146032 against anaerobic cocci |
| Q68826872 | Comparative antibacterial activity of the new oral cephalosporin BMY-28100 |
| Q37901752 | Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis |
| Q54412894 | Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. |
| Q70039675 | Comparative in vitro activity of A-56268 against respiratory tract pathogens |
| Q43635556 | Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci |
| Q54412807 | Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. |
| Q45245312 | Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative |
| Q37902524 | Comparative in vitro activity of RU 28965 against Chlamydia trachomatis |
| Q93683443 | Comparative in vitro activity of Sch 34343 against urea-splitting microorganisms |
| Q54409283 | Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test. |
| Q68775241 | Comparative in vitro activity of cefetamet (RO 15-8074) |
| Q70378913 | Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria |
| Q72827574 | Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy |
| Q57991345 | Comparative in vitro activity of norfloxacin against urinary tract pathogens |
| Q44432720 | Comparative in vitro activity of the new cyclic lipopeptide LY146032 against Corynebacterium species |
| Q44508409 | Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria |
| Q70039672 | Comparative in vitro activity of the new macrolide A-56268 against mycobacteria |
| Q41519835 | Comparative in vitro activity of the new oral cephalosporin BMY-28100. |
| Q69212232 | Comparative in vitro activity of the new penem CGP 31608 |
| Q69820154 | Comparative in vitro activity of the new peptolide antibiotic LY146032 against staphylococci |
| Q54427706 | Comparative in vitro activity of the new quinolone CI-934. |
| Q54399397 | Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074. |
| Q70175019 | Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin |
| Q72771816 | Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin |
| Q38591460 | Comparison of a biphasic medium plus routine early subculture with a slide blood culture system |
| Q37902539 | Comparison of a fluorescent monoclonal antibody assay and a tissue culture assay for routine detection of infections caused by Chlamydia trachomatis |
| Q71476714 | Comparison of a simplified liquid chromatographic assay of gentamicin in serum with enzyme immunoassay and bioassay |
| Q70753596 | Comparison of adherence and urine growth rate properties of Staphylococcus saprophyticus and Staphylococcus epidermidis |
| Q44377532 | Comparison of bronchial washing, brushing and biopsy for diagnosis of pulmonary tuberculosis |
| Q37902530 | Comparison of cell culture with two direct Chlamydia tests using immunofluorescence or enzyme-linked immunosorbent assay |
| Q45334189 | Comparison of cytopathic effect and an enzyme-linked immunosorbent assay using monoclonal antibodies for typing herpes simplex virus isolates |
| Q45832653 | Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera |
| Q69589797 | Comparison of enzyme-linked immunosorbent assay with coagglutination and latex agglutination for rapid diagnosis of pneumococcal pneumonia by detecting antigen in sputa |
| Q54440496 | Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. |
| Q70153710 | Comparison of four commercial assays for detection of rotavirus in childhood gastroenteritis |
| Q69809280 | Comparison of four methods for screening of cytomegalovirus antibodies in normal donors and immunocompromised patients |
| Q37907211 | Comparison of four serological methods for detecting antibodies to Chlamydia trachomatis |
| Q43594720 | Comparison of immunodiffusion and crossed-immunoelectrophoresis in the diagnosis of invasive candidiasis |
| Q68988448 | Comparison of immunological methods for diagnosis of pneumococcal pneumonia in biological fluids |
| Q69996536 | Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection |
| Q71184230 | Comparison of latex agglutination and counterimmunoelectrophoresis in the diagnosis of acute Streptococcus pneumoniae infections |
| Q41533211 | Comparison of micro-ID with API 20E for identification of Salmonella, Shigella and Yersinia species |
| Q37906829 | Comparison of microagglutination with the indirect immunofluorescence assay for the diagnosis of infection withLegionella pneumophila serogroup 1 |
| Q72123322 | Comparison of microscopic and cultural findings in the diagnosis of Gardnerella vaginalis infection |
| Q68671179 | Comparison of seven coagulase tests for identification of Staphylococcus aureus |
| Q70212646 | Comparison of six methods for detecting human rotavirus in stools |
| Q70598974 | Comparison of skin blisters and implanted cotton threads for the evaluation of antibiotic tissue concentrations |
| Q69892733 | Comparison of specimen transport systems for Bordetella pertussis |
| Q34707922 | Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues |
| Q50207861 | Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens |
| Q69589808 | Comparison of the latex agglutination inhibition assay for tobramycin with radioimmunoassay |
| Q54402641 | Comparison of the response of Escherichia coli to fosfomycin and fosmidomycin. |
| Q70283858 | Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin |
| Q72411075 | Comparison of three enzyme-linked immunosorbent assays suitable for the detection of antibodies to rotaviruses in epidemiological studies |
| Q42010914 | Comparison of three media for culture of Bordetella pertussis |
| Q41533532 | Comparison of three methods for identification of Enterobacteriaceae |
| Q53996342 | Comparison of three selective agars for isolation of campylobacters. |
| Q37902536 | Comparison of two enzyme immunoassays and an immunofluorescence test for detection of Chlamydia trachomatis |
| Q68224959 | Comparison of two selective blood agar media for the culture of group A streptococci from throats |
| Q93596700 | Comparison of two systems for identification of anaerobic bacteria |
| Q50203584 | Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5. |
| Q54479820 | Computer monitoring of gentamicin resistance in Czechoslovakia from 1972 to 1982. |
| Q51850593 | Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery. |
| Q68965845 | Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection |
| Q70377015 | Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid |
| Q43464349 | Construction of a penicillin-tolerant laboratory mutant of Staphylococcus aureus |
| Q68900909 | Contaminated lemons as possible source of infection in heroin abusers with disseminated candidiasis |
| Q68988444 | Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery |
| Q39665992 | Controversies in hospital infection control |
| Q54419184 | Conversion of a homogeneously methicillin-resistant strain of Staphylococcus aureus to heterogeneous resistance by Tn551-mediated insertional inactivation. |
| Q54516995 | Correlation between intestinal immune response to colonization factor antigen/I and acquired resistance to enterotoxigenic Escherichia coli diarrhea in an adult rabbit model. |
| Q54784699 | Correlation of predicted serum bactericidal activities and values measured in volunteers. |
| Q54313479 | Corynebacterium pseudodiphtheriticum associated with suppurative lymphadenitis. |
| Q69908487 | Cost and usefulness of clinical microbiology services |
| Q54490270 | Cotrimoxazole resistance in pneumococci. |
| Q52433407 | Criteria for interpretation of agar diffusion susceptibility tests of norfloxacin performed by the ICS method |
| Q71099968 | Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination |
| Q70373972 | Cross-reactivity of environmental bacteria with fluorescent-antibody conjugates for Legionella pneumophila |
| Q50203694 | Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria |
| Q54424223 | Cross-resistance of nalidixic acid resistant Enterobacteriaceae to new quinolones and other antimicrobials. |
| Q43690648 | Cryptosporidia in immunocompetent patients with gastroenteritis |
| Q68883546 | Cryptosporidiosis |
| Q39748652 | Current controversies in the detection of septicemia |
| Q39741092 | Current problems of chemotherapy of infections with coagulase-negative staphylococci |
| Q54473442 | DF-2: a fastidious fermentative gram-negative rod. |
| Q70321387 | Decreased sensitivity of Neisseria gonorrhoeae to quinolone compounds |
| Q70598987 | Detection of Streptococcus pneumoniae in blood culture specimens using counterimmunoelectrophoresis |
| Q43501915 | Detection of TEM beta-lactamase genes by non-isotopic spot hybridisation |
| Q70092635 | Detection of active Epstein-Barr infection in pregnant women |
| Q37902343 | Detection of adenovirus-specific immunoglobulin A in tears from patients with keratoconjunctivitis |
| Q93614504 | Detection of anaerobic bacteria in blood cultures by lysis filtration |
| Q55244690 | Detection of anti-HTLV-III/LAV antibody by enzyme-linked immunosorbent assay in high-risk individuals in Switzerland 1974-1985. |
| Q68161256 | Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis |
| Q69212239 | Detection of antigen in urine of a patient with tularemia |
| Q40820280 | Detection of central venous catheter-associated sepsis |
| Q68950286 | Detection of circulating antigens in immunocompromised patients during reactivation of chronic toxoplasmosis |
| Q69382581 | Detection of human rotavirus by nucleic acid analysis in comparison to enzyme-linked immunoassay and electron microscopy |
| Q68950282 | Detection of immunoglobulin M antibodies to Treponema pallidum in a modified enzyme-linked immunosorbent assay |
| Q54479823 | Detection of resistant isolates of Campylobacter jejuni by the disc susceptibility method. |
| Q70250370 | Detection time for blood culture isolates using a biphasic medium |
| Q67284992 | Determination of cefmenoxime in human body fluids by high-performance liquid chromatography |
| Q72742614 | Determination of the O-serovars ofPseudomonas aeruginosa by slide coagglutination |
| Q70182326 | Development of a monoclonal antibody specific for serotype 3 rotavirus strains |
| Q39665988 | Development of resistance during antibiotic therapy |
| Q45209804 | Diagnosis of Gardnerella vaginalis infection by an enzyme-linked immunosorbent assay |
| Q70562398 | Diagnosis of anaerobic infection by gas chromatographic estimation of volatile fatty acids |
| Q93572684 | Diagnosis of bacterial pneumonia with fiberoptic bronchoscopy |
| Q37902533 | Diagnosis of genital Chlamydia trachomatis infection in males by cell culture and antigen detection test |
| Q70598994 | Diagnosis of pneumococcal pneumonia by coagglutination and counterimmunoelectrophoresis of sputum samples |
| Q43803578 | Diagnosis of pneumococcal pneumonia by detection of antigen in saliva |
| Q68900903 | Diagnosis of systemic candidiasis: application of co-counterimmunoelectrophoresis |
| Q68900902 | Diagnosis of systemic candidiasis: development of co-counterimmunoelectrophoresis |
| Q64950332 | Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. |
| Q71296693 | Differentiation in throat cultures of group C and G streptococci from Streptococcus milleri with identical antigens |
| Q50904570 | Differentiation of obligate anaerobes by assay of pyruvate:ferredoxin oxidoreductase activity. |
| Q70644509 | Diffusion of ciprofloxacin into prostatic fluid |
| Q70331825 | Direct radioimmunoassay of antibody against hepatitis B core antigen using32P-labelled core particles |
| Q54412891 | Disk diffusion and disk elution tests with A-56268 and erythromycin. |
| Q72792127 | Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteria |
| Q71352306 | Disk sensitivity testing for Campylobacter jejuni |
| Q64132983 | Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin |
| Q58405790 | Disseminated infection caused byMycobacterium kansasii presenting as fever of unknown origin |
| Q72799640 | Dissemination of streptomycin and sulfonamide resistance by plasmid pBP1 in Escherichia coli |
| Q71462327 | Do selective media improve the recovery of group B streptococci? |
| Q70671878 | Does the occurrence of plasmids in Campylobacter jejuni and Campylobacter coli isolates correlate with antibiotic resistance? |
| Q70644512 | Dose- and sex-independent disposition of ciprofloxacin |
| Q64135514 | Dot-immunobinding assay with a monoclonal antibody for detection of group B meningococcal antigen |
| Q71462310 | Dwarf-colony variants of Escherichia coli from urine cultures: a possible disadvantage of the dip-slide technique |
| Q40822891 | Early diagnosis of Q fever: detection of immunoglobulin M by radioimmunoassay and enzyme immunoassay |
| Q68671183 | Edwardsiella tarda bacteremia |
| Q68681327 | Effect of BMY-28100, a new cephalosporin, on Staphylococcus aureus nasal carriage |
| Q45237578 | Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli |
| Q54409543 | Effect of Ro 23-6240 on sensitive and resistant intracellular mycobacteria. |
| Q45120814 | Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci |
| Q45795822 | Effect of alkaline glutaraldehyde on hepatitis B virus antigens |
| Q54490458 | Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes. |
| Q54421783 | Effect of changing selection pressures on trimethoprim resistance in Enterobacteriaceae. |
| Q93646776 | Effect of chlorhexidine and acetic acid on phagocytosis by polymorphonuclear leucocytes |
| Q69988797 | Effect of ciprofloxacin on phagocytosis |
| Q68769935 | Effect of enoxacin on colonic microflora of healthy volunteers |
| Q70598977 | Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract |
| Q71184243 | Effect of gentamicin on abscesses caused by Bacteroides species |
| Q71184247 | Effect of high doses of cefoperazone on stool flora |
| Q69589812 | Effect of human serum on inhibition of growth of Staphylococcus aureus by antimicrobial agents |
| Q69720531 | Effect of hypobaric oxygen and oleic acid on respiration of Staphylococcus aureus |
| Q54433533 | Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test. |
| Q45792354 | Effect of influenza virus on phagocytic cells |
| Q47227913 | Effect of inoculum size on in vitro susceptibility of methicillin-resistant Staphylococcus aureus to eighteen antimicrobial agents |
| Q54796798 | Effect of iron on neonatal gut flora during the first three months of life. |
| Q53727157 | Effect of iron on neonatal gut flora during the first week of life. |
| Q54440297 | Effect of iron on serotypes and haemagglutination patterns of Escherichia coli in bottle-fed infants. |
| Q72792151 | Effect of norfloxacin on Staphylococcus aureus and Pseudomonas aeruginosa in broth, serum and in combination with human polymorphonuclear leukocytes |
| Q54430813 | Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. |
| Q54796792 | Effect of pH on the rate of bactericidal activity of ampicillin against Escherichia coli strains. |
| Q70444790 | Effect of phenoxymethylpenicillin, erythromycin, lymecycline and doxycycline upon the release of proteases from human leukocytes |
| Q54792319 | Effect of radiographic contrast medium and bile on antimicrobial activity. |
| Q67244814 | Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus |
| Q64451391 | Effect of subinhibitory concentrations of josamycin on the expression of M protein by group A streptococci |
| Q64451536 | Effects of antibiotics on adhesion of enterotoxigenic Escherichia coli strains |
| Q70175010 | Effects of subinhibitory concentrations of ketoconazole on in vitro adherence ofCandida albicans to vaginal epithelial cells |
| Q71476718 | Effects of subminimal inhibitory concentrations of chloramphenicol, erythromycin and penicillin on group A streptococci |
| Q70153201 | Efficacy of ceftriaxone and gentamicin in an abscess model |
| Q43954423 | Efficacy of ciprofloxacin in treatment of CAPD peritonitis |
| Q71352281 | Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats |
| Q54131581 | Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis. |
| Q44649233 | Eight cases of Capnocytophaga infections in Denmark |
| Q70087326 | Elimination of fecal flora by cefoperazone |
| Q44181157 | Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment |
| Q50205634 | Emergence of multiple drug resistance among Salmonella species in Jordan |
| Q68830886 | Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins |
| Q54399389 | Emergence of urea-splitting multi-resistant coryneform bacteria (Corynebacterium group D2) as pathogens. |
| Q70753602 | Endocarditis caused by Actinobacillus actinomycetemcomitans |
| Q44754274 | Endocarditis due to Kingella kingae |
| Q53724094 | Endotoxin testing revisited. |
| Q37901122 | Enhanced susceptibility of trypsinized HeLa cells to Chlamydia trachomatis infection |
| Q69848479 | Enoxacin in the treatment of bronchopulmonary infections |
| Q93572656 | Enrichment media for isolation of Clostridium difficile from faeces |
| Q56794202 | Enterococcal urinary tract infections in a teaching hospital |
| Q70305489 | Enterococci and antifolate antibiotics |
| Q44095483 | Enterotoxigenicity among Salmonella typhimurium strains isolated in France |
| Q72797076 | Enterotoxigenicity ofStaphylococcus aureus strains from clinical isolates |
| Q64451697 | Enterotoxin production, invasive ability and surface antigens of enteropathogenicEscherichia coli |
| Q70479583 | Enzymatic profile of Mycobacterium tuberculosis |
| Q37900889 | Enzyme immunoassay and enzyme-linked fluoroimmunoassay for detection of Chlamydia trachomatis antigen |
| Q43430656 | Enzyme immunoassay for detection of Clostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis |
| Q47914549 | Enzyme immunoassay for detection of antigen in acute Plasmodium falciparum malaria |
| Q53880978 | Enzyme profile of Haemophilus ducreyi strains isolated on different continents. |
| Q44172493 | Enzyme-linked immunofiltration assay for rapid serodiagnosis of syphilis |
| Q45798585 | Enzyme-linked immunosorbent assay for detection and typing of herpes simplex virus |
| Q69949854 | Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins |
| Q69954272 | Enzyme-linked immunosorbent assay for detection of immunoglobulin G and M antibodies to teichoic acid in intravascular staphylococcal disease |
| Q44937117 | Enzyme-linked immunosorbent assay for detection of soluble Toxoplasma gondii antigen in acute-phase toxoplasmosis |
| Q40799787 | Enzyme-linked immunosorbent assay for diagnosis of brucellosis |
| Q37903935 | Enzyme-linked immunosorbent assay using three different antigen preparations for detection of antibodies to Chlamydia trachomatis |
| Q70493544 | Enzyme-linked lectinosorbent assay (ELLA) for detecting Bacillus anthracis |
| Q54399400 | Epidemiological aspects of Clostridium difficile in a pediatric hospital and its role in diarrheal disease. |
| Q68681316 | Epidemiology and prevention of Clostridium difficile infections in a leukemia unit |
| Q69908492 | Epidemiology of Shigella boydii serotype 2, a strain indigenous to Spain |
| Q37908149 | Epidemiology of chlamydial infection of the human genital tract: evidence for the existence of latent infections |
| Q43911909 | Epidemiology of human rotaviruses as determined by electrophoresis of genome RNA |
| Q68800068 | Episiotomy wound infection due to Gardnerella vaginalis |
| Q45836617 | Epstein-Barr virus-specific immunoglobulin A in patients with infectious mononucleosis, an age-dependent factor |
| Q41863940 | Ethidium bromide stain for early detection of septicemia |
| Q69617137 | Etiology of community-acquired pneumonia |
| Q43483033 | Etiology of community-acquired pneumonia in out-patients |
| Q37904275 | Etiology of community-acquired pneumonia in patients requiring hospitalization |
| Q54440128 | Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria. |
| Q71462322 | Evaluation of a commercially available semi-automated bioluminescence system for bacteriuria screening |
| Q69421583 | Evaluation of a new slide latex agglutination test for diagnosis of vaginal candidosis |
| Q37902505 | Evaluation of a seven day course of oxytetracycline in women with chlamydial cervicitis |
| Q45842536 | Evaluation of an enzyme immunoassay for detection of herpes simplex virus antigen in genital lesions |
| Q54430808 | Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. |
| Q43724611 | Evaluation of commercial test systems for the identification of nonfermenters |
| Q68830891 | Evaluation of disk approximation and agar dilution induction tests for demonstration of in vitro antagonism of cefotaxime by cefoxitin in Enterobacter species |
| Q71462316 | Evaluation of four commercial biochemical test systems for identification of yeasts |
| Q70283862 | Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test |
| Q69896058 | Evaluation of pertinent parameters of a new identification system for non-enteric gram-negative rods |
| Q69545428 | Evaluation of primary selective media and enrichment methods for Campylobacter species isolation |
| Q37902292 | Evaluation of roxithromycin in the treatment of non-gonococcal urethritis in males |
| Q54574559 | Evaluation of the Cobasbact automated antimicrobial susceptibility testing system. |
| Q44217399 | Evaluation of the Cobasbact system for rapid antimicrobial susceptibility testing of positive blood culture broths |
| Q70599019 | Evaluation of the MS-2 automated antimicrobial susceptibility testing system: report of a European collaborative study |
| Q69917675 | Evaluation of the Micro-ID, the API 20E and the Rapid 20E for same-day identification of Enterobacteriaceae |
| Q54508780 | Evaluation of the Micur microdilution systems for antibiotic susceptibility testing of gram-negative and gram-positive bacteria. |
| Q54388904 | Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis. |
| Q63567023 | Evaluation of the biomed bacteroides IF kit for identification ofBacteroides fragilis group strains |
| Q40816186 | Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q fever |
| Q37903693 | Evaluation of the direct fluorescent antibody test for diagnosis of chlamydial infections |
| Q69889058 | Evaluation of the new Mycotube test-kit for yeast identification |
| Q44690753 | Evaluation of the teichoic acid antibody assay using a commercial antigen |
| Q54440294 | Evaluation of three commercial tests for rapid detection of beta-lactamase in anaerobic bacteria. |
| Q45841879 | Evaluation of three methods for typing herpes simplex virus |
| Q44569783 | Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera |
| Q54455677 | Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii. |
| Q39822507 | Evolving epidemiology of Pseudomonas aeruginosa infections |
| Q69917682 | Examination of enteropathogens for production of immunoglobulin A1 protease |
| Q64135527 | Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci |
| Q46270099 | Experimental animal model of surgical wound infection applicable to antibiotic prophylaxis |
| Q70250363 | Experimental intraabdominal abscess formation byEscherichia coli andBacteroides fragilis |
| Q54784710 | Factors influencing the activity of the trometamol salt of fosfomycin. |
| Q68883549 | Faecal carriage of group B streptococci |
| Q37902508 | Fallopian tube obstruction as a sequela to Chlamydia trachomatis infection |
| Q64379693 | Fast identification of adenovirus 40/41 in infants with enteritis |
| Q45100356 | Fastidious gram-negative, facultatively anaerobic rods: a renewed interest |
| Q45082108 | Fatal Selenomonas sputigena septicemia probably originating from lung abscess |
| Q71824445 | Fatal meningitis with group JK Corynebacterium in a leukopenic patient |
| Q69056681 | Fatal multivalvular endocarditis due to Streptococcus milleri and Streptococcus sanguis |
| Q93614500 | Fatty acid composition of Streptococcus milleri |
| Q54419308 | Fecal colonization with pyelonephritogenic Escherichia coli in neonates as a risk factor for pyelonephritis. |
| Q57991280 | Field testing of modified Bieling media for the isolation ofHaemophilus ducreyi in Kenya |
| Q43514922 | Fimbriation in relation to hydrophobicity of bacteria in urinary tract infections |
| Q93614514 | First isolation of Neisseria polysacchareae species nova in the Federal Republic of Germany |
| Q70451371 | Flagellation is a strain-dependent characteristic of cystic fibrosis-associated mucoid strains of Pseudomonas aeruginosa |
| Q48941773 | Flavobacterium meningosepticum ventriculitis: In vivo and in vitro results with the combinations rifampicin-erythromycin and mezlocillin-cefoxitin |
| Q44104162 | Fluorescence-activated cell analysis of P-fimbriae receptor accessibility on uroepithelial cells of patients with renal scarring |
| Q43691108 | Fosfomycin in the treatment of cystic fibrosis |
| Q69908489 | Four cases of Shigella septicemia in Israel |
| Q70323212 | Four-hour direct identification ofEnterobacteriaceae in blood cultures |
| Q68805416 | Frequency and epidemiologic associations of different types of vaginitis in symptomatic women in Greece |
| Q69869568 | Frequency of plasmid-determined beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae |
| Q69949850 | Further characterization of the tracheal receptor for Pseudomonas aeruginosa |
| Q50165574 | Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile. |
| Q40254734 | Gardnerella vaginalis and its clinical syndrome |
| Q44507249 | Gardnerella vaginalis and non-specific vaginitis |
| Q72123319 | Gardnerella vaginalis and non-specific vaginitis. Introductory remarks |
| Q69870877 | Gardnerella vaginalis in urinary tract infections of immunocompromised patients |
| Q44559264 | Gardnerella vaginalis in urinary tract infections of renal allograft patients |
| Q68681340 | Gas chromatographic comparison of peptone yeast glucose and gas liquid chromatography growth media for anaerobic bacteria |
| Q93646775 | Gas chromatographic fatty acid profiles for characterisation of mycobacteria: an interlaboratory methodological evaluation |
| Q70634531 | Gas chromatographic study of cellular fatty acids of comma-shaped bacteria isolated from the vagina |
| Q68681348 | Gas chromatographically quantitated lactate in empyema and other pleural effusions |
| Q93614509 | Gastric juice microflora in patients with gastric ulcer and gastric cancer |
| Q54418903 | Genetic analysis of methicillin-resistant Staphylococcus aureus from Singapore hospitals. |
| Q70323217 | Gentamicin bioassay with increased sensitivity |
| Q43449043 | Gram stain of uncentrifuged urine for rapid detection of leukocyturia |
| Q43634617 | Group B streptococcal endocarditis in Down's syndrome |
| Q93646779 | Group JK corynebacteria in skin flora of healthy persons and patients |
| Q70995491 | HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase |
| Q53918525 | Haemagglutination patterns of diarrhoea-associatedEscherichia coli strains in South Africa |
| Q71705553 | Hepatitis A virus infection. Summary of discussion and statement of opinions on selected issues at an international workshop |
| Q50579330 | Hepatitis B vaccination campaign in a low endemicity area. |
| Q71066218 | Hepatitis B vaccination of high-risk individuals in the canton of Zurich |
| Q72401503 | Herpes simplex virus infections |
| Q70388360 | Heterogeneity of apparently pure anaerobic cultures: a possible source of error in susceptibility testing |
| Q53884386 | Heterosexual transmission of AIDS: no time for complacency. |
| Q54758007 | High frequency of isolation of Campylobacter coli from poultry meat in France. |
| Q54779589 | High-level trimethoprim resistance in urinary bacteria. |
| Q71296751 | Histopathological study of lymph nodes in patients with lymphadenopathy or acquired immune deficiency syndrome |
| Q44473982 | Host defence mechanisms, antibiotics and immunosuppressive agents--a complex relationship |
| Q70562394 | How antibiotics augment host defenses |
| Q69878375 | Hydrolysis of third-generation cephalosporins by Enterobacter cloacae beta-lactamase |
| Q69617142 | Hydrophobic and adherence properties of Clostridium difficile |
| Q44785498 | Identification of Clostridium difficile using the API ZYM system |
| Q68928203 | Identification of staphylococci by the API Staph, Sceptor, Rosco and simplified lyogroup systems |
| Q60214701 | Identification ofClostridium difficile by detection of p-cresol in a cooked meat medium |
| Q54467055 | Imipenem/cilastatin. |
| Q40824000 | Immunological aspects of humidifier fever |
| Q71296747 | Immunological studies in homosexual men with unexplained lymphadenopathy |
| Q68933999 | Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F |
| Q70963564 | Impact of imipenem/cilastatin therapy on faecal flora |
| Q54454947 | Impact of short perioperative courses of cefotaxime on aerobic bacterial flora in patients undergoing transurethral prostatic resection. |
| Q43621612 | Impaired production of alpha and gamma interferon in asymptomatic homosexual males |
| Q70354785 | Importance of carbenicillin and gentamicin cross-resistant serotype 0:12 Pseudomonas aeruginosa in six Athens hospitals |
| Q68836889 | In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100 |
| Q45834678 | In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains |
| Q68818813 | In vitro activity of BMY 28100, a new oral cephalosporin |
| Q54493671 | In vitro activity of HR 810, a new broad-spectrum cephalosporin |
| Q54412795 | In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria. |
| Q54412797 | In vitro activity of LY146032 (daptomycin), a new peptolide. |
| Q54522110 | In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria. |
| Q70344681 | In vitro activity of RO 15-8074 and RO 19-5247 |
| Q43440685 | In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum |
| Q68812392 | In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis |
| Q69942672 | In vitro activity of azthreonam and Ro 17-2301 against multiresistant Pseudomonas aeruginosa strains |
| Q70301985 | In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa |
| Q68809065 | In vitro activity of cefetamet (Ro 15-8074) |
| Q54517075 | In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method |
| Q72389296 | In vitro activity of ceftizoxime combined with aminoglycosides against clinical bacterial strains |
| Q70226571 | In vitro activity of ciprofloxacin against Bacteroides, Haemophilus influenzae and Branhamella catarrhalis |
| Q70644514 | In vitro activity of ciprofloxacin against Brucella melitensis |
| Q43441418 | In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis |
| Q72827585 | In vitro activity of ciprofloxacin against group JK Corynebacteria |
| Q54399394 | In vitro activity of ciprofloxacin against methicillin-susceptible and methicillin-resistant staphylococci. |
| Q67298686 | In vitro activity of ciprofloxacin against mycobacteria |
| Q72827581 | In vitro activity of ciprofloxacin and norfloxacin againstGardnerella vaginalis |
| Q70501704 | In vitro activity of ciprofloxacin, azthreonam and ceftazidime against Serratia marcescens and Pseudomonas aeruginosa |
| Q72787640 | In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid |
| Q54455847 | In vitro activity of enoxacin compared with norfloxacin and amikacin. |
| Q42208712 | In vitro activity of five new quinolones against cultivable mycobacteria |
| Q70087329 | In vitro activity of five quinoline derivatives against nosocomial isolates of Staphylococcus and Pseudomonas species |
| Q42208714 | In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria |
| Q69212250 | In vitro activity of four new quinolones in Mueller-Hinton broth and peritoneal dialysis fluid |
| Q70963565 | In vitro activity of imipenem against anaerobic bacteria |
| Q40192467 | In vitro activity of imipenem--a review |
| Q71352310 | In vitro activity of josamycin, a macrolide antibiotic, against microaerophilic campylobacter |
| Q70354792 | In vitro activity of new antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients |
| Q72792142 | In vitro activity of norfloxacin against multi-resistant bacteria |
| Q43442073 | In vitro activity of norfloxacin againstChlamydia trachomatis |
| Q72799644 | In vitro activity of norfloxacin againstMycoplasma hominis andUreaplasma urealyticum |
| Q72792146 | In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid |
| Q54511930 | In vitro activity of seventeen antimicrobial agents againstGardnerella vaginalis |
| Q54455849 | In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci. |
| Q72789826 | In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci |
| Q72809972 | In vitro activity of teicoplanin and vancomycin against anaerobes |
| Q43441651 | In vitro activity of temocillin (BRL 17421) against Chlamydia trachomatis |
| Q54433715 | In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests. |
| Q70344678 | In vitro activity of the new 4-quinolone compound Ro 23-6240 |
| Q70362958 | In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae |
| Q37902572 | In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis |
| Q69421593 | In vitro activity of the two new oral cephalosporins RO 15-8074 and RO 19-5247 |
| Q72585874 | In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers |
| Q69421596 | In vitro activity of various new antimicrobial agents against group JK corynebacteria |
| Q69421586 | In vitro and in vivo susceptibility of Borrelia burgdorferi |
| Q44632608 | In vitro and in vivo synergy between ceftriaxone and aminoglycosides againstPseudomonas aeruginosa |
| Q50211421 | In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents |
| Q54433537 | In vitro antimicrobial susceptibility of penicillinase-producing Neisseria gonorrhoeae in Japan. |
| Q70021654 | In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent |
| Q54487198 | In vitro emergence ofEscherichia coli andPseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid |
| Q69212227 | In vitro evaluation of the new paulomycin antibiotic paldimycin |
| Q68900898 | In vitro killing of erythromycin-exposed group A streptococci by polymorphonuclear leukocytes |
| Q70290200 | In vitro phagocytosis of Candida albicans by human polymorphonuclear phagocyte monolayers pretreated with anti-pseudomonal antibiotics |
| Q54468124 | In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate |
| Q71476710 | In vitro stimulation of Bacteroides fragilis growth by Escherichia coli |
| Q54427711 | In vitro studies of S-25930 and S-25932, two new 4-quinolones. |
| Q70644492 | In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to sulfadiazine, sulfisoxazole and sulfathiazole |
| Q42207655 | In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin |
| Q70354787 | In vitro susceptibility of Neisseria gonorrhoeae to RO 23-6240 and ciprofloxacin |
| Q70323231 | In vitro susceptibility ofEikenella corrodens to thirteen beta-lactam antibiotics and fosfomycin |
| Q68194936 | In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance |
| Q48222467 | In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice |
| Q45797650 | Inactivation of hepatitis A virus added to pooled human plasma by beta-propiolactone treatment and ultraviolet irradiation |
| Q69617139 | Incidence and significance of candida antigen in low-risk and high-risk patient populations |
| Q69589800 | Incidence and virulence of Aeromonas species in feces of children with diarrhea |
| Q70362953 | Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance |
| Q44785835 | Incidence, predisposing factors and manifestations of invasiveHaemophilus influenzae infections in adults |
| Q44291063 | Increased frequency of isolation of Pasteurella and Actinobacillus species and related organisms |
| Q54476238 | Increasing resistance of Bacteroides fragilis group strains to metronidazole in Spain between 1977 and 1982. |
| Q68830878 | Inducible beta-lactamases. Enzymes of increasing clinical importance |
| Q57077296 | Induction of meningeal inflammation by diverse bacterial cell walls |
| Q40817473 | Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever |
| Q45836255 | Infection with human T-lymphotropic virus type III and leukocyte interferon production in homosexual men. |
| Q43642482 | Influence of Escherichia coli on Streptococcus faecalis in mixed cultures and experimental animal infections |
| Q69056674 | Influence of antibiotics on fibronectin binding and phagocytosis of staphylococci by human polymorphonuclear leukocytes |
| Q68812393 | Influence of antibiotics on intestinal mucin in healthy subjects |
| Q69212263 | Influence of cefoperazone on neutrophil functions in volunteers |
| Q47233116 | Influence of culture medium and inoculum size on susceptibility ofBordetella pertussis to antibacterial agents in vitro |
| Q70323224 | Influence of probenecid on serum and subcutaneous tissue fluid concentrations of benzylpenicillin and ceftazidime in human volunteers |
| Q54470833 | Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes. |
| Q50210557 | Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid |
| Q70362960 | Inhibition of growth of Mycobacterium tuberculosis in the presence of auramine |
| Q70599030 | Insensitivity of several bacteria and fungi to the magnetic field generated by a bone stimulator |
| Q67294686 | Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro |
| Q43538663 | Interaction of mezlocillin and cefoxitin againstProteus morganii in the granuloma pouch model |
| Q54758415 | Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins. |
| Q72822465 | Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations |
| Q72747663 | Interferons and viral infections |
| Q54455679 | Interpretive criteria for temocillin disk diffusion susceptibility testing. |
| Q93572674 | Interpretive standards of cefbuperazone disk diffusion susceptibility tests |
| Q41533772 | Intestinal occurrence of Campylobacter fetus subspecies jejuni and Clostridium difficile in children in Sweden |
| Q71762828 | Intestinal occurrence of Campylobacter jejuni in a French hospitalized population |
| Q69996528 | Intraperitoneal penetration of ciprofloxacin |
| Q69720536 | Intraphagocytic activity of ciprofloxacin and CI 934 |
| Q71705555 | Iron and host defence |
| Q93683438 | Iron and infection |
| Q71762832 | Isolation and identification of Yersinia enterocolitica requires incubation temperatures below 37 degrees C |
| Q70562407 | Isolation and serotyping of Yersinia pseudotuberculosis in humans in Japan |
| Q68988464 | Isolation frequency of Aeromonas species in relation to patient age |
| Q93614512 | Isolation of Actinobacillus actinomycetemcomitans from a skin lesion |
| Q54386125 | Isolation of Aeromonas species from animals. |
| Q69589805 | Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles |
| Q93614520 | Isolation of Campylobacter species by filtration |
| Q54402066 | Isolation of Corynebacterium group D2 from clinical specimens. |
| Q68988473 | Isolation of Escherichia fergosonii from a patient with septicemia in France |
| Q36489019 | Isolation of Legionella anisa from a hospital hot water system |
| Q36612647 | Isolation of Mobiluncus in four cases of extragenital infections in adult women |
| Q50167669 | Isolation of Moellerella wisconsensis from an infected human gallbladder |
| Q69589803 | Isolation of Pasteurella multocida in a patient with spontaneous peritonitis and liver cirrhosis |
| Q68826876 | Isolation of Trichomonas vaginalis from cycloheximide-treated McCoy cells |
| Q70753607 | Isolation of a previously undescribed Vibrionaceae |
| Q71352292 | Isolation of an unusual Cedecea species from a cutaneous ulcer |
| Q41348476 | Ketoconazole pharmacokinetics during chronic dosing in adults with haematological malignancy |
| Q71462332 | Klebsiella pneumoniae colonization of the bowel associated with the use of trimethoprim-sulfamethoxazole |
| Q69820158 | LY146032 treatment of Clostridium difficile colitis in hamsters |
| Q39754517 | Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the USA. |
| Q61439625 | Laboratory diagnosis of infections caused by legionellae |
| Q34183542 | Laboratory diagnosis of infections caused by legionellae. |
| Q53841127 | Lack of cross-resistance between imipenem and other beta-lactam antibiotics for Pseudomonas aeruginosa. |
| Q70262433 | Lack of immunoglobulin A protease in Neisseria lactamica |
| Q69421601 | Lack of invasiveness of Campylobacter pylori |
| Q71762824 | Latex agglutination test for detection of Candida antigen in patients with disseminated disease |
| Q46970238 | Lectin-mediated bacterial adhesion to human tissue |
| Q40211173 | Lectins in diagnostic microbiology |
| Q69056678 | Legionella pneumophila in a physiotherapy pool |
| Q43849178 | Legionella pneumophila in a water distribution system |
| Q58379910 | Legionnaires disease in northern Italy |
| Q70671874 | Legionnaires' disease in north-western Greece |
| Q70412695 | Limitations in the use of the clover leaf test in Bacteroides species |
| Q68818816 | Liver abscess due to Haemophilus influenzae type b |
| Q93614517 | Loss of viability of Bacteroides fragilis and Bacteroides vulgatus in different media |
| Q93614528 | Lyme arthritis: does endotoxin play a role? |
| Q41608970 | Lysis and biodegradation of microorganisms in infectious sites may involve cooperation between leukocyte, serum factors and bacterial wall autolysins: a working hypothesis |
| Q68950290 | Lysis centrifugation and slide blood culture systems for diagnosis of bacteremia in immunocompromised patients |
| Q70506405 | Magnitude of bacteremia and complement activation during Neisseria meningitidis infection: study of two co-primary cases with different clinical presentations |
| Q68872327 | Measurement of bactericidal activity in body fluids as a clinical research procedure |
| Q48464001 | Meningitis and brain abscess due to Haemophilus paraphrophilus |
| Q69589815 | Meningitis caused by Fusobacterium necrophorum |
| Q46951395 | Meningitis due to Cryptococcus neoformans biovar gattii in a Zairean AIDS patient |
| Q43902579 | Methicillin susceptibility testing of Staphylococcus aureus on media containing five percent sodium chloride |
| Q57113802 | Method for selecting optimal cells for enterovirus isolation as determined in an outbreak of echovirus type 33 meningitis |
| Q44038292 | Method for testing adherence of Haemophilus influenzae to human buccal epithelial cells |
| Q70087319 | Microbial colonization of the oropharynx, esophagus and stomach in patients with gastric diseases |
| Q69864374 | Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland |
| Q70644488 | Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp |
| Q70312203 | Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro |
| Q69820150 | Modulation of human neutrophil and monocyte oxidative burst by Legionella pneumophila sonic extract |
| Q54433626 | Molecular genetics of exopolysaccharide production by mucoid Pseudomonas aeruginosa. |
| Q54419181 | Molecular typing of methicillin and gentamicin resistant Staphylococcus aureus in Dublin. |
| Q47212767 | Molecular weight of the major outer membrane protein of Legionella pneumophila |
| Q93683440 | Molecular weight of the major outer membrane protein of Legionella pneumophila |
| Q40112128 | Monoclonal antibodies against microorganisms |
| Q69917674 | Monoclonal antibodies to immunodominant surface-exposed protein antigens of Treponema pallidum |
| Q45996100 | Monoclonal antibodies: a potentially powerful tool in the diagnosis and treatment of infectious diseases. |
| Q68950288 | Monospecific antibodies for detection of Clostridium difficile enterotoxin |
| Q70274796 | Morphological changes inBacteroides fragilis andKlebsiella pneumoniae attributable to growth in the presence of various antibiotics |
| Q69949868 | Multicenter study of the sensitivity of Pseudomonas aeruginosa to antimicrobial agents |
| Q40796804 | Multicentre evaluation of a direct coagglutination test for group A streptococci |
| Q68988462 | Multiply resistant Streptococcus mitis isolated from conjunctival exudate of newborns |
| Q52588252 | Multivariate analysis of antibiograms for typing Pseudomonas aeruginosa. |
| Q54471095 | Mutational resistance to 4-quinolone antibacterial agents |
| Q40160214 | Mycoplasma hominis — A neglected human pathogen |
| Q70087333 | Mycoplasma-like structures in a Kaposi's sarcoma not associated with AIDS |
| Q53794595 | Neonatal conjunctivitis caused by Pasteurella ureae. |
| Q45053490 | Neonatal septicemia in Stockholm |
| Q70362949 | Netilmicin disk susceptibility tests: effect of cations on the MIC correlates |
| Q39743442 | New developments in the diagnosis of opportunistic fungal infection |
| Q39822500 | New insights into the epidemiology, pathogenesis and therapy of Pseudomonas aeruginosa infections |
| Q39665996 | New microbiological techniques for hospital epidemiology |
| Q43940652 | New serogroups of Neisseria meningitidis isolated in the Federal Republic of Germany |
| Q70515753 | Niacin, nitrate and pyrazinamide studies using Middlebrook 7H10 Broth |
| Q61446806 | Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections |
| Q38584320 | Nucleic acids in the classification of campylobacters |
| Q72683851 | Occurrence and immunogenicity of proteinases fromLegionella species |
| Q44192736 | Occurrence of P-fimbriated Escherichia coli in patients with bacteremia |
| Q43930049 | Occurrence of antigenically distinct rotaviruses in infants in Bulgaria |
| Q40833427 | Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children |
| Q71352276 | Opsonic activity of fibronectin in the phagocytosis of Staphylococcus aureus by polymorphonuclear leukocytes |
| Q71634211 | Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains |
| Q54402062 | Optochin resistance in Streptococcus pneumoniae strains isolated from blood and middle ear fluid. |
| Q40819156 | Outbreak of haemorrhagic fever with renal syndrome in Greece |
| Q45827876 | Outbreak of respiratory syncytial virus in France |
| Q39502910 | Overview of clinical experience with ciprofloxacin |
| Q70479585 | Paradoxial effect of slime produced by Pseudomonas aeruginosa on the bactericidal activity of chlorhexidine |
| Q43439423 | Paratrachoma: an important complication of urogenital chlamydial infection |
| Q70586199 | Pasteurella multocida septicemia not associated with primary liver disease |
| Q43468944 | Pasteurella ureae meningitis as complication of skull fractures |
| Q64451591 | Pathogenicity of piliated and encapsulatedBacteroides fragilis |
| Q43635583 | Penetration of ciprofloxacin into bronchial secretions |
| Q69996520 | Penetration of ciprofloxacin into cerebrospinal fluid |
| Q69996524 | Penetration of ciprofloxacin into female pelvic tissues |
| Q69996530 | Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue |
| Q71352289 | Penicillin concentrations in blood and spinal fluid after a single intramuscular injection of penicillin G benzathine |
| Q58405861 | Penicillin-resistantStreptococcus pneumoniae meningitis successfully treated with vancomycin |
| Q70323201 | Performance of two four-hour identification systems with atypical strains ofEnterobacteriaceae |
| Q70191498 | Perinatal viral infections |
| Q45794697 | Persistence of immunoglobulin M antibody to hepatitis A virus and relapse of hepatitis A infection |
| Q71296742 | Persistent lymphadenopathy in patients at risk of contracting acquired immune deficiency syndrome |
| Q71762840 | Perspectives and controversies in the prevention of infection in granulocytopenic patients |
| Q39665986 | Perspectives on the potential for successful development of outer membrane protein vaccines |
| Q36605659 | Pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients |
| Q70175025 | Pharmacokinetic and microbial susceptibility studies of ceftriaxone |
| Q70599023 | Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination |
| Q68783053 | Pharmacokinetics and tissue penetration of orally administered pefloxacin |
| Q44440824 | Pharmacokinetics of antibiotics in the elderly |
| Q68681333 | Pharmacokinetics of aztreonam in very low birthweight neonates |
| Q69996516 | Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses |
| Q70644505 | Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers |
| Q51634358 | Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. |
| Q69617146 | Pharmacokinetics of ciprofloxacin in peripheral lymph and skin blisters |
| Q69854213 | Pharmacokinetics of imipenem-cilastatin in serum and tissue |
| Q44577373 | Pharmacokinetics of intravenous antibiotics in acutely ill elderly patients |
| Q40837135 | Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora |
| Q72792132 | Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage |
| Q54493673 | Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid |
| Q38583110 | Phenotypic differentiation of Cardiobacterium hominis, Kingella indologenes and CDC group EF-4. |
| Q38583112 | Phenotypic differentiation of Pasteurella sensu stricto and the Actinobacillus group |
| Q40184516 | Pneumocystis carinii: a misunderstood opportunist |
| Q37900892 | Pneumonia--1987: new developments |
| Q68805420 | Polymorphonuclear leukocyte, T-lymphocyte, and natural killer cell activities in elderly nursing home residents |
| Q69018358 | Possible confusion of Aspergillus fumigatus and Pneumocystis carinii |
| Q43903289 | Possible pathogenic implications of right-sided polymicrobial endocarditis in a heroin abuser |
| Q70354776 | Post-antibiotic effect of ciprofloxacin on Pseudomonas aeruginosa |
| Q70232766 | Post-pneumonectomy empyema caused by non-typableHaemophilus influenzae biotype III |
| Q70437161 | Post-transfusion hepatitis and its association with pooled clotting factors |
| Q41562962 | Potential significance of colonization with beta-lactamase-producingHaemophilus parainfluenzae in children |
| Q72792119 | Potential usefulness of norfloxacin in the treatment of urinary tract infections |
| Q68228495 | Predictive value of surveillance cultures for systemic infection due to Candida species |
| Q70331833 | Preliminary evaluation of a passive hemagglutionation assay and enzyme-linked immunosorbent assay for actinomycetoma caused byNocardia brasiliensis |
| Q70353607 | Presence of alveolar macrophages as a criterion for determining the suitability of sputum specimens for bacterial culture |
| Q45796849 | Presence of viral antibodies to the human lymphoma-leukemia virus in patients with acquired immune deficiency syndrome |
| Q93572661 | Presumptive identification of anaerobic gram-positive cocci by disc inhibition zone diameters |
| Q69589818 | Prevalence of Staphylococcus saprophyticus in patients in a venereal disease clinic |
| Q44747115 | Prevalence of antibodies to herpes simplex virus type 1 in different population groups in Italy |
| Q45828538 | Prevalence of antibody to delta hepatitis virus in population groups in West Germany and Switzerland |
| Q54516998 | Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim. |
| Q71462286 | Production of enterotoxin by Escherichia coli at four, twenty-two and thirty-seven degrees centigrade |
| Q40170409 | Progress in immunization againstKlebsiella infections |
| Q70599034 | Properties of Yersinia enterocolitica strains isolated from ankylosing spondylitis patients |
| Q54799151 | Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization. |
| Q50205975 | Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides |
| Q93572679 | Pseudomonas aeruginosa infections |
| Q44121997 | Pseudomonas species Ve-2 septicemia |
| Q44908689 | Puerperal Pasteurella multocida septicemia |
| Q54177199 | Pulmonary actinomycosis with endobronchial involvement. |
| Q40200454 | Pyogenic liver abscess: diagnosis, bacteriology and treatment |
| Q70223269 | Pyridinium 2-azo-p-dimethylaniline chromophore, a chromogenic reagent for beta-lactamase testing compared to nitrocefin |
| Q44934185 | Quantitative urine cultures revisited |
| Q70292955 | Radiometric diagnosis of mycobacteria |
| Q45797039 | Rapid and direct detection of herpes simplex virus and varicella-zoster virus antigens in clinical specimens by staphylococcal reagent and membrane filtration |
| Q70323208 | Rapid bioluminescent assay for determining netilmicm and tobramycin concentrations in serum |
| Q45292588 | Rapid coagglutination test for the direct detection of group A streptococci from throat swabs |
| Q68161262 | Rapid commercial test for direct detection of group A streptococci in throat swabs |
| Q72118871 | Rapid detection of Haemophilus influenzae type b in cerebrospinal fluid by commercial coagglutination and latex agglutination kits |
| Q50205774 | Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies |
| Q41425431 | Rapid enzymatic characterization of clinically encountered anaerobic bacteria with the API ZYM system |
| Q68988477 | Rapid grouping of beta-haemolytic streptococci |
| Q70586193 | Rapid identification of Capnocytophaga isolated from septicemic patients |
| Q69545424 | Rapid identification of Clostridium difficile by determination of leucine arylamidase activity |
| Q70274790 | Rapid identification ofStreptococcus pyogenes by flow cytometry |
| Q69899865 | Rapid immunoelectrophoretic assay for detection of serum antibodies to Aspergillus fumigatus catalase in patients with pulmonary aspergillosis |
| Q69720545 | Rapid method for identification of Enterobacteriaceae in urinary tract infections |
| Q71462296 | Rapid separation of immunoglobulin M by immunoaffinity chromatography for detection of specific antibodies to rubella and Treponema pallidum |
| Q53914520 | Rarity of Legionella species in routine sputum specimens. |
| Q70300610 | Rate of isolation ofStaphylococcus aureus strains possessing coagulase or clumping factor |
| Q40200463 | Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis |
| Q69949858 | Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A |
| Q69901004 | Recovery of Bordetella pertussis from four kinds of swabs |
| Q68681334 | Recovery of Moraxella urethralis from clinical material |
| Q71296697 | Reduced efficacy of sulfitolysed intravenous immunoglobulin |
| Q67298679 | Reduced enteral absorption of ciprofloxacin in the presence of antacids |
| Q43785667 | Reduction of experimental wound infection rate by administration of clindamycin in addition to netilmicin |
| Q33446251 | Regulation of macrophage phagocytosis |
| Q70169073 | Relation between beta-lactamase production and antimicrobial activity: Comparison of the new compound HR 810 with cefotaxime |
| Q37902578 | Relationship between Chlamydia trachomatis infection and elevated serum immunoglobulin M levels in premature infants |
| Q40824280 | Relationship between growth temperature and shedding of lipopolysaccharides by gram-negative bacilli |
| Q69870875 | Relationship of beta-lactamase production to growth phase in Bacteroides species |
| Q54516989 | Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. |
| Q58234766 | Relative proportions ofHaemophilus species in the throat of healthy children and adults |
| Q54433630 | Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. |
| Q54412802 | Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens. |
| Q70963561 | Renal clearance of imipenem in children |
| Q69617149 | Renal elimination of sulfo-ciprofloxacin, a new metabolite of ciprofloxacin |
| Q70753611 | Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth |
| Q45269813 | Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics |
| Q40817480 | Retrospective analysis of two hundred and twelve cases of bacteremia due to anaerobic microorganisms |
| Q70250350 | Retrospective comparison of three blood culture media for the recovery of yeasts from clinical specimens |
| Q68942710 | Retrospective investigation of transfusion-related non-A, non-B viral hepatitis associated with M2 antigen |
| Q54200333 | Role of Tamm-Horsfall protein in the pathogenesis of reflux nephropathy and chronic pyelonephritis. |
| Q61906430 | Role of activated T lymphocytes in mycosis fungoides |
| Q70089750 | Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections |
| Q42215645 | Role of individual serum pentitol concentrations in the diagnosis of disseminated visceral candidiasis |
| Q69878371 | Role of splenectomy in the pathogenesis of Haemophilus influenzae type f meningitis |
| Q71705546 | Rotavirus infections in a pediatric clinic |
| Q71705550 | Routine bioluminescence urine screening |
| Q69661766 | Roxithromycin bioassay procedures for human plasma, urine and milk specimens [corrected and issued with original paging in Eur J Clin Microbiol 1986 Dec;5(6)] |
| Q71476722 | Salt aggregation test for measuring cell surface hydrophobicity of urinary Escherichia coli |
| Q55245489 | Searching for the cause of the acquired immune deficiency syndrome |
| Q68681320 | Selection and counting of aerobic gram-negative bacilli in saliva by the spiral system |
| Q42512259 | Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics |
| Q70599009 | Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics |
| Q37900909 | Sensitivity of mitomycin-C treated McCoy cells for isolation of Chlamydia trachomatis from genital specimens |
| Q67294678 | Sensitivity of urinary staphylococci to ciprofloxacin and acrosoxacin |
| Q68928202 | Sensitivity testing with ketoconazole in an assay containing Candida albicans, human polymorphonuclear leukocytes and serum |
| Q36482176 | Septic melioidosis after a visit to Southeast Asia |
| Q70586205 | Septicemia caused by Kingella kingae |
| Q45008979 | Serogroups and biotypes of human strains of Campylobacter jejuni and Campylobacter coli isolated in France |
| Q61479987 | Seroimmunity to poliovirus in poitiers France |
| Q43509649 | Serological diagnosis of Mediterranean spotted fever by the immunoperoxidase reaction |
| Q46733542 | Serological evaluation of the outer membrane protein complexes of five saccharolytic intestinal Bacteroides species |
| Q41519572 | Serological studies in Crohn's disease |
| Q64451963 | Serological subtypes of Escherichia coli colonization factor antigen II |
| Q43654183 | Serotype distribution of Streptococcus pneumoniae in hospitalized patients in Israel |
| Q70466089 | Serotyping of 153 group B and C meningococci isolated in France, 1981-1982 |
| Q71066228 | Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens |
| Q43019668 | Serotyping of Campylobacter species by combined use of two methods |
| Q70196701 | Serum and cerebrospinal fluid levels of cefotaxime in neurosurgical patients |
| Q45134076 | Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers |
| Q70283852 | Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa |
| Q43408133 | Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens |
| Q69487970 | Serum bactericidal assay. Technical aspects and clinical correlations |
| Q39588559 | Serum bactericidal test in volunteers--a review |
| Q69992935 | Serum bactericidal titer as a predictor of outcome in endocarditis |
| Q68872320 | Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents |
| Q71634206 | Serum-induced lysis of Pseudomonas aeruginosa |
| Q39666001 | Setting priorities: nationwide nosocomial infection prevention and control programs in the USA. |
| Q40160208 | Severe infections caused by methicillin-resistantStaphylococcus aureus |
| Q72799636 | Siderophores as antimicrobial agents |
| Q68161267 | Significance of antibodies to Mycoplasma genitalium in salpingitis |
| Q44413248 | Single and multiple dose pharmacokinetics of ciprofloxacin |
| Q72411083 | Single-dose antimicrobial prophylaxis in open heart surgery |
| Q71352285 | Six cases of acute appendicitis with secondary peritonitis caused by Streptococcus pneumoniae |
| Q37904114 | Solid-phase enzyme immunoassay for detection of Chlamydia trachomatis |
| Q70250366 | Some observations on the Biken test for the detection of enterotoxigenic Escherichia coli |
| Q54513686 | Speciation and antibiotic susceptibility patterns of coagulase-negative staphylococci. |
| Q70598989 | Speciation of coagulase-negative staphylococci in the clinical laboratory |
| Q70753599 | Species-specific immunodiagnosis of human echinococcosis with crude antigens |
| Q36448199 | Specific and nonspecific immunodiagnostic properties of recombinant and synthetic Plasmodium falciparum antigens |
| Q93572667 | Specificity of ELISA anti-immunoglobulin G conjugate in the diagnosis of human brucellosis |
| Q50921336 | Spectral analysis of biochemical reactions used for identification of bacteria. |
| Q39731812 | Standardization of the serum bactericidal test and its relationship to levels of antimicrobial agents |
| Q38353862 | Static and dynamic properties of tissue cage fluid in rabbits |
| Q43796650 | Status of a group B Neisseria meningitidis vaccine |
| Q70292959 | Stevens-Johnson syndrome with isolation of Mycoplasma pneumoniae from skin lesions |
| Q93614506 | Stomatococcus mucilaginosus endocarditis |
| Q54418666 | Strategies for typing and properties of epidemic methicillin-resistant Staphylococcus aureus. |
| Q45831405 | Streptococcal protein G: a sensitive tool for detection of antibodies to human immunodeficiency virus proteins in Western blot analysis |
| Q72381359 | Streptococci with dual antigen specificity for Lancefield groups D and G |
| Q39223270 | Streptococcus milleri infection of a hepatopulmonary hydatid cyst |
| Q43743953 | Stress ulcer prophylaxis and the risk of nosocomial pneumonia in artificially ventilated patients |
| Q70331822 | Subcellular fractions in rubella immunoassays |
| Q48466257 | Successful treatment of nocardial thigh abscess and possible brain abscess with co-trimoxazole |
| Q48202651 | Successful treatment of recurrent cerebral empyema and brain abscesses with imipenem |
| Q93596707 | Support of the single species concept for Streptococcus milleri by DNA hybridization data |
| Q41523823 | Suppurative lymphadenitis with Yersinia enterocolitica |
| Q71066231 | Survival of Campylobacter jejuni in the presence of bisulfite and different atmospheres |
| Q70644501 | Susceptibility of Campylobacter fetus subsp. jejuni to paromomycin |
| Q70182328 | Susceptibility of Clostridium difficile to LY146032 |
| Q69421608 | Susceptibility of Clostridium difficile to metronidazole, its bioactive metabolites and tinidazole |
| Q54467051 | Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics. |
| Q70644516 | Susceptibility of Legionella spp. to quinolone derivatives and related organic acids |
| Q70963567 | Susceptibility of Mycobacterium fallax to imipenem and twenty other antimicrobial agents |
| Q54486623 | Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid. |
| Q70599015 | Susceptibility of gram-negative bacteria isolated from the blood of cancer patients |
| Q54493215 | Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810. |
| Q68916398 | Susceptibility of group B and group G streptococci to newer antimicrobial agents |
| Q63762157 | Susceptibility ofBacteroides fragilis to cefotaxime and piperacillin: Tentative interpretative standards for the disc-diffusion test |
| Q57676144 | Susceptibility ofCampylobacter species to niridazole |
| Q68671161 | Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance |
| Q54440290 | Susceptibility to tobramycin determined by a modified agar dilution method with a high inoculum. |
| Q43466714 | Suspected airport malaria in Spain |
| Q70599002 | Synergism of trimethoprim combined with aminoglycosides in vitro and in serum of volunteers |
| Q54399403 | Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. |
| Q50210662 | Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin |
| Q54433712 | Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. |
| Q93646781 | Systemic candidiasis in drug addicts |
| Q69835585 | Systemic infection with Trichosporon capitatum in two patients with acute leukaemia |
| Q39731823 | Technical aspects and clinical correlations of the serum bactericidal test |
| Q93614498 | Testing phagocytic cell function |
| Q37905501 | The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitro |
| Q72830148 | The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin againstStreptococcus faecalis |
| Q70373977 | The cultivation and rapid enzyme identification of DF-2 |
| Q71762844 | The diagnosis and treatment of toxoplasmosis |
| Q43882306 | The great cephalosporin wars |
| Q54471098 | The in vitro and in vivo activity of ciprofloxacin |
| Q71184235 | The influence of metronidazole and its two main metabolites on murine in vitro lymphocyte transformation |
| Q40254743 | The odour of non-specific vaginitis: a review |
| Q70753588 | The penetration of antibiotics into the prostate in chronic bacterial prostatitis |
| Q70963558 | The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers |
| Q70175016 | The potential uses of ceftriaxone |
| Q70598998 | The pros and cons of beta-lactam antibiotics: profusion and confusion |
| Q70599005 | The radioactive thymidine incorporation method for the determination of antibiotic susceptibility of gram-negative bacilli |
| Q72123324 | The vaginal microbial flora in non-specific vaginitis |
| Q44800484 | Three cases of bacteremia with group Ve-2 bacteria in France |
| Q72411079 | Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo |
| Q70354795 | Towards a global perspective of nosocomial infections |
| Q70598983 | Toxic shock syndrome in the Federal Republic of Germany |
| Q68988440 | Toxoplasmosis in immunocompromised patients |
| Q54452873 | Trafficking of Pseudomonas exotoxin A in mammalian cells. |
| Q68228506 | Transient fungemia and Candida arthritis due to Candida zeylanoides |
| Q69917678 | Treatment of Legionella lung abscess in a renal transplant recipient with erythromycin and fusidic acid |
| Q69896060 | Treatment of Pseudomonas aeruginosa septicemia in neutropenic patients with ceftazidime |
| Q68764416 | Treatment of abdominothoracic actinomycosis with imipenem |
| Q68916396 | Treatment of bacterial meningitis |
| Q42120843 | Treatment of chronic salmonella carriers with ciprofloxacin |
| Q54486351 | Treatment of gram-negative bacillary septicemia with cefoperazone. |
| Q68988457 | Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain |
| Q54147087 | Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. |
| Q37902783 | Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin |
| Q44271164 | Trichomonas species in a subhepatic abscess |
| Q68988453 | Trivial pursuits: a game microbiologists play |
| Q39847297 | Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center |
| Q41518629 | Two-hour miniaturized system for detection of enteropathogenic bacteria in stool cultures |
| Q68681343 | Ultrasensitive analysis of microbial fatty acids using gas chromatography with electron capture detection |
| Q69917671 | United Kingdom National External Quality Assessment Scheme for Microbiology |
| Q68988480 | Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolides |
| Q70292965 | Unusual clinical features of an epidemic of listeriosis associated with a particular phage type |
| Q70223281 | Upper urinary tract infection withGardnerella vaginalis in a woman |
| Q41329471 | Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. |
| Q40192454 | Uraemia--does it affect host resistance to infectious disease? |
| Q71296738 | Urinary neopterin in the diagnosis of acquired immune deficiency syndrome |
| Q68681339 | Urinary neopterin: an early marker of HIV infection |
| Q68954941 | Urinary tract infection probably caused by Agrobacterium radiobacter |
| Q44571334 | Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections |
| Q54452283 | Use of discriminative models of Pseudomonas aeruginosa bacteremia in granulocytopenic rats for testing antimicrobial efficacy. |
| Q70331829 | Use of hepatitis B core antigen produced inEscherichia coli to detect immunoglobulin M specific antibodies in an enzyme-linked immunosorbent assay |
| Q45830945 | Use of monoclonal antibodies for rapid detection of influenza A virus in nasopharyngeal secretions |
| Q69589823 | Use of skirrow medium with membrane filters for selective isolation of Campylobacter jejuni from stools |
| Q43516773 | Use of the antimicrobial removal device prior to blood culture in patients on antibiotic therapy |
| Q37907353 | Use of the enzyme-linked immunosorbent assay for detection of antibodies toChlamydia trachomatis |
| Q70479580 | Use of the enzyme-linked immunosorbent assay for the early diagnosis of Mycoplasma pneumoniae infection |
| Q43822232 | Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa |
| Q70354780 | Value of isotypic characterization of antibodies to Echinococcus granulosus by enzyme-linked immuno-filtration assay |
| Q39731817 | Value of the serum bactericidal test in management of patients with bacterial endocarditis |
| Q54418668 | Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives? |
| Q71296679 | Vancomycin: renewed interest in an old drug |
| Q70437165 | Variation in morphological response of resistant clinical isolates of Pseudomonas aeruginosa to carbenicillin |
| Q71762836 | Virulence of stock cultures of Staphylococcus aureus 248 beta H in poor soft nutrient agar |
| Q58862619 | Visceral leishmaniasis in a patient seropositive for HIV |
| Q43730779 | Waterborne outbreak of Campylobacter enteritis |
| Q70430378 | Which bacterial species should be isolated from throat cultures? |
| Q68916401 | Widal-type serology using live antigen for diagnosis of Shigella flexneri dysentery |
| Q45828161 | Woodchuck hepatitis virus infection: serologic and histopathologic course and outcome |
| Q39673641 | World-wide development of antibiotic resistance in pneumococci |
| Q70412691 | Wound infection rates after intraincisional plus systemic antibiotic prophylaxis in an animal model |
| Q53910809 | Wound infection rates following preoperative versus intraoperative commencement of antibiotic prophylaxis. |
| Q64893268 | “Pneumocystis carinii”-A misunderstood enigma |
| Q44603892 | Culture ofBorrelia burgdorferi on six solid media | cites work | P2860 |
Search more.